Peter Altman - Jun 30, 2025 Form 4 Insider Report for BioCardia, Inc. (BCDA)

Role
President and CEO, Director
Signature
/s/ David McClung, by power of attorney
Stock symbol
BCDA
Transactions as of
Jun 30, 2025
Transactions value $
$49,999
Form type
4
Date filed
7/2/2025, 09:02 PM
Previous filing
May 30, 2025
Next filing
Aug 11, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Altman Peter President and CEO, Director C/O BIOCARDIA, INC., 320 SOQUEL WAY, SUNNYVALE /s/ David McClung, by power of attorney 2025-07-02 0001647542

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCDA Common Stock Purchase $50K +24.1K +17% $2.08 166K Jun 30, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCDA Warrant (right to buy) Purchase +24.1K +33.69% 95.6K Jun 30, 2025 Common Stock 24.1K $1.95 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 30, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased.